4//SEC Filing
Okazaki Jason A 4
Accession 0000950170-24-038630
CIK 0001426800other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:05 PM ET
Size
5.5 KB
Accession
0000950170-24-038630
Insider Transaction Report
Form 4
Okazaki Jason A
DirectorCEO and President
Transactions
- Sale
Common Stock
2024-03-27$12.87/sh−392$5,045→ 14,180 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Reflects equitable adjustment of the number of shares of common stock beneficially owned by the reporting person as a result of a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2024, which is exempt from reporting pursuant to Rule 16a-9.
Documents
Issuer
ASSEMBLY BIOSCIENCES, INC.
CIK 0001426800
Entity typeother
Related Parties
1- filerCIK 0001807214
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:05 PM ET
- Size
- 5.5 KB